Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Higgs

Showing results (131-140 of 171) with videos related to

Pageof 18
Sort By:
Journal of Addictive Diseases|July 21, 2021
Drug type and risk behaviors associated with non-fatal overdose among people who use drugs: a systematic review and meta-analysisBahram Armoon, Neda SoleimanvandiAzar, Mohammad Rostami, et al.
Journal of Viral Hepatitis|January 21, 2025
Australian Community Pharmacists' Preparedness to Offer and Discuss Hepatitis C Testing and Treatment With Pharmacy Clients: A Representative Cross-Sectional SurveyElissa Ong, Ting Xia, Rose Laing, et al.
Journal of Viral Hepatitis|February 26, 2019
Community-based, point-of-care hepatitis C testing: perspectives and preferences of people who inject drugsNed H Latham, Alisa Pedrana, Joseph S Doyle, et al.
Addiction (Abingdon, England)|August 15, 2025
Qualitative analysis of barriers and facilitators to healthcare engagement for people with injecting-related invasive infections using a social ecological frameworkLucy O Attwood, Sophia E Schroeder, Olga Vujovic, et al.
The Medical Journal of Australia|June 9, 2012
Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, AustraliaMargaret E Hellard, Rebecca Jenkinson, Peter Higgs, et al.
The International Journal on Drug Policy|November 20, 2019
Treading lightly: Finding the best way to use public health surveillance of hepatitis C diagnoses to increase access to cureMark Stoové, Jack Wallace, Peter Higgs, et al.
Biodemography and Social Biology|March 19, 2019
Social and demographical determinants of quality of life in people who live with HIV/AIDS infection: evidence from a meta-analysisHesam Ghiasvand, Peter Higgs, Mehdi Noroozi, et al.
The International Journal on Drug Policy|June 15, 2015
Hepatitis C transmission and treatment as prevention - The role of the injecting networkMargaret Hellard, Emma McBryde, Rachel Sacks Davis, et al.
Iranian Journal of Psychiatry|July 5, 2021
Prevalence of Substance Use among Psychotic Patients and Determining Its Strongest PredictorSeyedeh Bentolhoda Mousavi, Peter Higgs, Negar Piri, et al.
The International Journal on Drug Policy|May 31, 2021
"It's time!": A qualitative exploration of the acceptability of hepatitis C notification systems to help eliminate hepatitis CShelley Walker, Jack Wallace, Ned Latham, et al.
Pageof 18

Showing results (131-140 of 171) with videos related to

Sort By:
Pageof 18
Journal of Addictive Diseases|July 21, 2021
Drug type and risk behaviors associated with non-fatal overdose among people who use drugs: a systematic review and meta-analysisBahram Armoon, Neda SoleimanvandiAzar, Mohammad Rostami, et al.
Journal of Viral Hepatitis|January 21, 2025
Australian Community Pharmacists' Preparedness to Offer and Discuss Hepatitis C Testing and Treatment With Pharmacy Clients: A Representative Cross-Sectional SurveyElissa Ong, Ting Xia, Rose Laing, et al.
Journal of Viral Hepatitis|February 26, 2019
Community-based, point-of-care hepatitis C testing: perspectives and preferences of people who inject drugsNed H Latham, Alisa Pedrana, Joseph S Doyle, et al.
Addiction (Abingdon, England)|August 15, 2025
Qualitative analysis of barriers and facilitators to healthcare engagement for people with injecting-related invasive infections using a social ecological frameworkLucy O Attwood, Sophia E Schroeder, Olga Vujovic, et al.
The Medical Journal of Australia|June 9, 2012
Modelling antiviral treatment to prevent hepatitis C infection among people who inject drugs in Victoria, AustraliaMargaret E Hellard, Rebecca Jenkinson, Peter Higgs, et al.
The International Journal on Drug Policy|November 20, 2019
Treading lightly: Finding the best way to use public health surveillance of hepatitis C diagnoses to increase access to cureMark Stoové, Jack Wallace, Peter Higgs, et al.
Biodemography and Social Biology|March 19, 2019
Social and demographical determinants of quality of life in people who live with HIV/AIDS infection: evidence from a meta-analysisHesam Ghiasvand, Peter Higgs, Mehdi Noroozi, et al.
The International Journal on Drug Policy|June 15, 2015
Hepatitis C transmission and treatment as prevention - The role of the injecting networkMargaret Hellard, Emma McBryde, Rachel Sacks Davis, et al.
Iranian Journal of Psychiatry|July 5, 2021
Prevalence of Substance Use among Psychotic Patients and Determining Its Strongest PredictorSeyedeh Bentolhoda Mousavi, Peter Higgs, Negar Piri, et al.
The International Journal on Drug Policy|May 31, 2021
"It's time!": A qualitative exploration of the acceptability of hepatitis C notification systems to help eliminate hepatitis CShelley Walker, Jack Wallace, Ned Latham, et al.
Pageof 18